Blood Test Tracking for HRT (Hormone Replacement Therapy) Users

What Happens to Your Blood Markers When You Start HRT

When oestrogen levels are restored through HRT — whether via patch, gel, or oral tablet — several blood markers shift in predictable ways. FSH, which rises steeply in menopause as the pituitary tries to stimulate failing ovaries, typically falls with adequate oestrogen replacement. Measuring FSH before initiating HRT and again at three to six months provides objective confirmation that the dose is physiologically meaningful — or flags under-dosing if FSH remains elevated despite symptomatic treatment.

Oral oestrogen, unlike transdermal forms, undergoes significant hepatic first-pass metabolism and can raise thyroxine-binding globulin (TBG). Elevated TBG binds more thyroid hormone, which can cause hypothyroid symptoms even when total T4 appears normal. Women with hypothyroidism who switch to oral HRT often need their levothyroxine dose increased. TSH is the most reliable single thyroid marker to monitor after starting oral oestrogen — if it rises, a conversation with both your prescriber and your endocrinologist is warranted. The thyroid blood tests guide explains this interaction in detail.

Lipid panels also shift: oral oestrogen tends to raise triglycerides and HDL; effects on LDL are variable and formulation-dependent. For women with pre-existing hypertriglyceridaemia, transdermal oestrogen is generally preferred as it does not raise triglycerides. Enter lipid values in Health3 via the OCR parser to build a pre- and post-HRT comparison. The cholesterol test guide provides context for interpreting these changes.

Bone Health Markers During Menopause and HRT

Oestrogen suppresses osteoclast activity — the cells that break down bone — and its loss in menopause accelerates bone turnover and can reduce bone mineral density by 1–3% per year in the early postmenopausal period, and occasionally higher in the first 1–2 years, before the rate slows. HRT slows this process, but the degree of protection depends on adequate vitamin D and calcium status working alongside it. Bone density scans (DEXA) are the gold standard, but blood markers provide actionable interim data between scans.

Vitamin D should ideally be in the optimal range — not merely above the deficiency threshold — for effective bone protection. Oestrogen influences vitamin D activation and calcium absorption in the gut; as oestrogen declines, the same vitamin D level becomes less effective, meaning postmenopausal women may need higher supplementation than premenopausal women to achieve the same bone-protective effect. The vitamin D guide covers optimal ranges in detail.

Serum calcium is tightly regulated by parathyroid hormone and rarely falls simply from dietary insufficiency — but it is a useful safety check when vitamin D is very low or supplementation is aggressive. Persistent low or high calcium warrants investigation beyond dietary adjustments. Magnesium is essential for parathyroid hormone function and bone mineralisation; deficiency impairs the calcium-vitamin D axis even when both calcium and vitamin D appear adequate. Visit the bone health topic for a structured view of these inter-related markers.

Iron, Cortisol, and the Perimenopausal Fatigue Picture

Fatigue is among the most commonly reported perimenopausal symptoms, and it has multiple simultaneous contributors that blood tests can systematically disentangle. Heavy or irregular periods — common in the perimenopause transition — are a significant source of iron loss. Ferritin below the optimal range produces fatigue, reduced exercise tolerance, and cognitive effects before haemoglobin falls, making it the most sensitive marker to monitor if heavy periods are present. The iron and anaemia topic and the ferritin guide explain how to interpret results across the full spectrum from iron depletion to deficiency anaemia.

Sleep disruption — from night sweats, anxiety, or the neurological effects of oestrogen withdrawal — elevates cortisol. Chronically elevated cortisol accelerates bone loss (by antagonising osteoblast function), suppresses immune function, and worsens mood — overlapping substantially with the symptoms HRT is designed to address. A single morning cortisol test does not capture the full diurnal pattern, but a consistently elevated or low morning result provides useful contextual information when symptoms persist despite apparently adequate HRT dosing.

Magnesium deficiency contributes to sleep disruption, muscle cramps, and low mood — symptoms that overlap with perimenopausal complaints. Many women are subclinically deficient on a standard Western diet, and the issue intensifies when sleep disruption increases urinary magnesium losses. Use Health3's biomarker interactions guide to understand how magnesium, vitamin D, and calcium function as a system rather than independent markers.

Building a Monitoring Routine That Works Alongside Your HRT

A practical baseline panel before starting HRT should include FSH, TSH, lipid panel, fasting glucose, liver enzymes (for oral HRT), vitamin D, calcium, magnesium, and ferritin. At three to six months after initiation, repeat FSH (to confirm oestrogen adequacy) and TSH (if on oral oestrogen or thyroid medication). Annual monitoring thereafter should include lipid panel, vitamin D, calcium, and B12 alongside your regular HRT review.

Health3's blood work frequency guide provides a framework for planning monitoring cadence. The blood test prep checklist ensures results are comparable across draws — particularly important for hormonal markers, which can vary with the time of day and where you are in any residual cycle. Use the unit converter if your labs report oestradiol in pmol/L versus pg/mL across different providers.

Pinning FSH, TSH, vitamin D, and ferritin to your Health3 favourites dashboard gives you an at-a-glance view of the markers most relevant to your therapy every time you log in. Export your full timeline as a PDF for each HRT review appointment so your prescriber can see trends rather than a single snapshot.

Medical disclaimer: Health3 is a biomarker tracking and educational tool, not a medical device. HRT is a prescription treatment that requires ongoing clinical supervision. Blood test results — including FSH, TSH, or lipid changes — should be discussed with your prescribing clinician before making any adjustments to your therapy. Do not start, stop, or change HRT based on blood results alone.

Key Biomarkers to Track

Health Topics That Matter Most

• Hormonal Balance — FSH, cortisol, and DHEA-S changes during perimenopause and menopausal HRT create a hormonal landscape that benefits from structured, longitudinal tracking.
• Bone Health — Oestrogen is the primary protector of bone density; its decline in menopause accelerates bone turnover, making vitamin D and calcium monitoring essential during HRT.
• Thyroid Health — Oral oestrogen raises TBG, which can mask or unmask thyroid dysfunction; women on thyroid medication and HRT simultaneously need more frequent thyroid monitoring.

How Health3 Helps

• Biomarker Trending: Track how your biomarker values change over time with visual trend charts. Spot patterns that single snapshots miss.
• Test Comparison: Compare two blood tests side by side to see exactly what changed between draws.
• Optimal vs Normal Ranges: See whether your values are merely normal or truly optimal. Health3 distinguishes between standard lab ranges and evidence-based optimal ranges.
• Weekly Insights: Receive personalized, science-backed insights each week based on your latest biomarker values.
• PDF Export: Export your test results and full history as clean, branded PDF reports to share with your doctor.

Track Your Biomarkers With Health3

Scan your lab results, explore biomarker interactions, and track trends over time with the Health3 app.